The Company is principally engaged in developing, manufacturing and distributing health and nutritional supplements in China, in compliance with Chinese requisite licenses and approvals. The Company also expands its business scope to develop, manufacture and distribute Chinese herbal extract products and GMP certified western prescriptive medicine through the acquisition with Tianfang by Heilongjiang Weikang.
Advanced Description :
Hello,
I think that they may have completed their capital raise. Maybe without the overhang it will be free to rise. Also, I would imagine that they will increase IR efforts.
Maj